LNTH
NASDAQ
$104.40
Lantheus Holdings Inc (LNTH)
Lantheus Holdings, Inc. develops, manufactures and markets diagnostic and therapeutic agents and products that assist physicians in the diagnosis and treatment of heart, cancer and other diseases worldwide. The company is headquartered in North Billerica, Massachusetts.
Sector:
Healthcare
Buy
Target: $111.58 (+6.88%)
Market Cap
$6.79B
Revenue 5Y CAGR
+35.28%
FCF 5Y CAGR
+89.22%
Profit Margin
31.4%
Price Chart
Valuation
Market Cap$6.79B
P/E25.18
Forward P/E18.98
PEG1.60
P/S4.31
P/B5.50
Profitability
Total Revenue (TTM)$1.55B
Gross Profit (TTM)$935M
EBITDA$393M
Profit Margin31.4%
Operating Margin21.6%
EPS$4.14
Financial Health
Debt-to-Equity0.1%
Free Cash Flow Yield6.01%
Growth & Risk
Revenue 5Y CAGR+35.28%
FCF 5Y CAGR+89.22%
Beta (5Y)0.41
Sharpe Ratio0.92